← Eichor
Study identifier: NCT06367725 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density

Condition: Acute Lymphoblastic Leukemia  ·  Sponsor: University of Aarhus

PhaseN/A
Planned participants100
Who can joinAll sexes, 1 Year to 17 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn about systemic and central nervous system (CNS) exposure to dexamethasone in childhood acute lymphoblastic leukaemia (ALL). The main questions it aims to answer are: * How does the intake of dexamethasone correlate with systemic exposure to dexamethasone in blood? * How does systemic exposure to dexamethasone correlate with dexamethasone concentrations in cerebrospinal fluid (CSF)? * Is dexamethasone exposure in blood and CSF associated with clearance of leukemic CNS infiltration? * Does systemic and/or CNS exposure to dexamethasone correlate with neurotoxicity as assessed by questionnaires? * Does systemic exposure to dexamethasone correlate with a reduction in bone mineral density? Participants will: * Continue to receive the best available therapy for ALL in Western Europe. * Have blood samples taken from their central line to measure dexamethasone levels. * When standard lumbar punctures are performed as part of treatment, an additional sample of cerebrospinal fluid will be collected to analyse dexamethasone concentrations and assess leukemic CNS involvement when applicable. * Visit the clinic four times for DXA scans to measure bone density and perform vertebral fracture assessment: within three weeks of starting treatment, six months after starting treatment, one month after finishing treatment, and one year after finishing treatment. Biomarkers related to bone health will also be collected on these days. * Complete va…

This description comes directly from the study's public registry record.

Talk to the study team

Birgitte K Albertsen, Professor  ·  +45 2022 4643  ·  biralber@rm.dk

Karen S Jensen, phd  ·  +45 61718432  ·  kascje@rm.dk

Always discuss trial participation with your own doctor first.

Locations (4)

Department of Paediatrics and Adolescent Medicine, Aalborg University HospitalAalborg, Aalborg, DenmarkRecruiting
Department of Paediatrics and Adolescent Medicine, Aarhus University HospitalAarhus N, Aarhus N, DenmarkRecruiting
Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital RigshospitaletCopenhagen, København Ø, DenmarkRecruiting
Department of Paediatrics and Adolescent Medicine, Odense University HospitalOdense, Odense C, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06367725